BACKGROUND
FOCUS AREAS
Over 20 years of experience in the Life Sciences industry spanning both technical and leadership roles.
Commercial Strategy and Execution
Team Leadership and Development
Product Development and Launch
Revenue Optimization and Profitability
Serving as Senior Vice President of Business Development, Sarah Haverin provides leadership to all aspects of ELIQUENT’s commercial organization to drive revenue growth and uncover market expansion opportunities. Adept at balancing innovation with proven RA/QA approaches, Sarah fosters cross-functional collaboration to deliver compelling solutions that exceed customer expectations.
By maintaining a keen understanding of customer needs and competitive dynamics, Sarah develops differentiated value propositions that resonate in the marketplace and make it easy for our clients to say “YES!” to working with ELIQUENT. Working on the ongoing design and development of global pricing models and sales enablement programs, she translates technical capabilities into market-ready products and services. Leveraging customer-centric design principles and agile development methodologies, Sarah leads diverse teams to enhance product scalability and product portfolio lifecycle management. This expertise strengthens competitive advantage and contributes to the sustained growth of the organization.
With over 20 years of experience in the biotechnology and life sciences space, Sarah is passionate about supporting companies of all sizes to bring new technologies to patients for the betterment of global healthcare. Sarah has held research positions at the Monash Medical Centre and the Hudson Institute of Medical Research as well as leadership positions within the medical device, pharma, and IVD RA/QA consulting spaces.
-
EDUCATION:
Master of Science in Clinical Drug Development, Queen Mary University of London
Bachelor of Science in Biomedical Sciences, University of Reading -
AREAS OF EXPERTISE:
MAAs and lifecycle maintenance (EU and UK)
Regulatory Strategy
Labelling
Ready for Regulatory Clarity?
Stay informed as the regulatory landscape evolves. Subscribe to our blog to receive the latest updates on policy changes, FDA developments, and their impact on the life sciences industry.